"Palmitic Acids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of 16-carbon fatty acids that contain no double bonds.
Descriptor ID |
D010169
|
MeSH Number(s) |
D10.251.694
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Palmitic Acids".
Below are MeSH descriptors whose meaning is more specific than "Palmitic Acids".
This graph shows the total number of publications written about "Palmitic Acids" by people in this website by year, and whether "Palmitic Acids" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 4 | 0 | 4 |
2018 | 3 | 0 | 3 |
2019 | 1 | 0 | 1 |
2020 | 1 | 0 | 1 |
2021 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Palmitic Acids" by people in Profiles.
-
Randomized clinical trial "olfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. intervention treatment with Palmitoylethanolamide and Luteolin": preliminary results. Eur Rev Med Pharmacol Sci. 2021 06; 25(11):4156-4162.
-
Micronized / ultramicronized palmitoylethanolamide (PEA) as natural neuroprotector against COVID-19 inflammation. Prostaglandins Other Lipid Mediat. 2021 06; 154:106540.
-
Sodium chromo-glycate and palmitoylethanolamide: A possible strategy to treat mast cell-induced lung inflammation in COVID-19. Med Hypotheses. 2020 Oct; 143:109856.
-
The neuroprotective effects of micronized PEA (PEA-m) formulation on diabetic peripheral neuropathy in mice. FASEB J. 2019 10; 33(10):11364-11380.
-
Effects of a new compound containing Palmitoylethanolamide and Baicalein in myocardial ischaemia/reperfusion injury in vivo. Phytomedicine. 2019 Feb 15; 54:27-42.
-
Adelmidrol + sodium hyaluronate in IC/BPS or conditions associated to chronic urothelial inflammation. A translational study. Pharmacol Res. 2018 08; 134:16-30.
-
Palmitoylethanolamide as adjunctive therapy for autism: Efficacy and safety results from a randomized controlled trial. J Psychiatr Res. 2018 08; 103:104-111.
-
A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models. BMC Vet Res. 2017 Aug 02; 13(1):229.
-
Palmitoylethanolamide and Polydatin combination reduces inflammation and oxidative stress in vascular injury. Pharmacol Res. 2017 Sep; 123:83-92.
-
Effects of a co-micronized composite containing palmitoylethanolamide and polydatin in an experimental model of benign prostatic hyperplasia. Toxicol Appl Pharmacol. 2017 08 15; 329:231-240.